|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.210 EGP | +0.83% |
|
-0.82% | +6.14% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 690M 14.04M 12.28M 11.28M 10.52M 19.95M 1.34B 20.25M 135M 52.66M 657M 52.72M 51.59M 2.27B | P/E 2026 * |
20.2x | P/E 2027 * | 13.4x |
|---|---|---|---|---|---|
| Enterprise Value | 610M 12.42M 10.86M 9.98M 9.3M 17.64M 1.18B 17.91M 120M 46.58M 581M 46.63M 45.63M 2B | EV / Sales 2026 * |
0.51x | EV / Sales 2027 * | 0.37x |
| Free-Float |
95.08% | Yield 2026 * |
2.48% | Yield 2027 * | 3.31% |
| 1 day | +0.83% | ||
| 1 week | -0.82% | ||
| Current month | +0.83% | ||
| 1 month | -5.47% | ||
| 3 months | -9.02% | ||
| 6 months | +8.04% | ||
| Current year | +6.14% |
| 1 week | 1.17 |  | 1.23 |
| 1 month | 1.17 | | 1.3 |
| Current year | 1.02 | | 1.68 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 2001-12-31 |
Tamir Saeed
BRD | Director/Board Member | - | 2020-12-31 |
Norbert Lurz
BRD | Director/Board Member | - | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.83% | -0.82% | -42.38% | -57.69% | 14.04M | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +31.35% | +24.29% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.97% | +4.04% | +23.66% | +46.27% | 369.24B | |
| Weighted average by Cap. | +2.25% | +5.53% | +41.78% | +83.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 24.22M 21.18M 19.46M 18.14M 34.41M 2.31B 34.93M 234M 90.82M 1.13B 90.93M 88.97M 3.91B | 1.55B 31.59M 27.62M 25.38M 23.66M 44.87M 3.01B 45.55M 305M 118M 1.48B 119M 116M 5.1B |
| Net income | 206M 4.19M 3.67M 3.37M 3.14M 5.96M 399M 6.05M 40.44M 15.72M 196M 15.74M 15.4M 676M | 283M 5.76M 5.04M 4.63M 4.31M 8.18M 549M 8.31M 55.56M 21.6M 270M 21.62M 21.16M 929M |
| Net Debt | -79.7M -1.62M -1.42M -1.3M -1.21M -2.3M -154M -2.34M -15.65M -6.08M -75.93M -6.09M -5.96M -262M | -110M -2.24M -1.96M -1.8M -1.68M -3.18M -213M -3.23M -21.6M -8.4M -105M -8.4M -8.22M -361M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-01 | EGP 1.210 | +0.83% | 12,771,226 |
| 26-06-30 | EGP 1.200 | +0.84% | 24,152,606 |
| 26-06-29 | EGP 1.190 | +0.85% | 19,965,038 |
| 26-06-28 | EGP 1.180 | -3.28% | 16,849,640 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.210EGP
Average target price
1.570EGP
Spread / Average Target
+29.75%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
